Most cancer therapies aim to destroy tumour cells, leaving the surrounding normal cells untouched. This is the basis of one treatment, involving a mutated adenovirus that is thought to destroy only those cells that lack the tumour-suppressor protein p53. But new research indicates that the adenovirus may actually require p53 to replicate, meaning that it would instead target healthy cells.